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SSOs decrease SR-B1 (A), Malat1 (B) and PTEN (C) mRNA expression in mouse liver. Balb/C mice were given a single dose of SSOs (50, 16, 5 and 1.6 mg/kg). 72 hrs after dosing, animals were sacrificed and livers removed. Total RNA was extracted from the liver. mRNA levels for the respective genes was quantified using real-time RT-PCR. The increase seen in SR-B1 mRNA by the PTEN and Malat1 SSOs was not observed in other experiments. Mean values +/-standard deviations (n=5).
Fig. S2
Cell surface proteins of MHT cells are involved in SSO uptake. MHT cells were either trypsinized or detached with 5 mM EDTA and then put in 96 well plates. Increasing concentrations of SSO were added to complete medium for 40'. Cells were washed and incubated in complete medium for 24 hrs. SR-B1 mRNA reduction was measured 24 hrs later using qRT-PCR. Mean values and SD were measured from triplicate samples. µM methyl-β-cyclodextrin and 1 µg/ml lovastatin were added to cells 30' before adding indicated concentrations of SSO to complete medium. Target reduction was measured 24 hrs later using qRT-PCR. Mean values and SD were measured from triplicate samples.
Fig. S6
Dynasore had no effect on SR-B1 target reduction by SR-B1 SSO. Left panel: Increasing concentrations of SR-B1 SSO were added to complete medium to MHT cells (black line) or cells were pretreated with 10 µM dynasore before adding SR-B1 SSO at indicated concentrations. Dynasore was kept in medium during SSO treatment. 24 hours later SR-B1 mRNA reduction was measured with qRT-PCR. Right panel: MHT cells were treated with 75 nM ctr siRNA, dynamin siRNA and clathrin siRNA. 48 hrs later 80 nM SR-B1 SSO was added to cells. 24 hours later SR-B1 mRNA reduction was measured with qRT-PCR. Mean values and SD were measured from triplicate samples.
Fig. S7
Inhibition of AP2M1 inhibits SSO uptake and target reduction. MHT cells were transfected with 100 nM control siRNA or AP2M1 siRNA. 48 hrs later the SSO 407988 (AF488-conjugated SR-B1 ASO) was added at indicated concentrations to complete medium of MHT cells. 24 hrs later uptake of AF488-conjugated SR-B1 SSO was measured with flow Cytometry (A) and SR-B1 target reduction (B) was measured with qRT-PCR. Mean values and SD were measured from triplicate samples.
Fig. S8
SSOs do not localize in P-bodies. 100 nM fluorescein-conjugated SR-B1 ASO was added to MHT cells. P-bodies were stained with p54RCK/DDX6 antibody from Bethyl Labs (Bethyl BL2142, A300-461A).
